<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67898">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02221934</url>
  </required_header>
  <id_info>
    <org_study_id>003-0001</org_study_id>
    <nct_id>NCT02221934</nct_id>
  </id_info>
  <brief_title>Electrical Nerve Block for Amputation Pain</brief_title>
  <official_title>High-Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuros Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuros Medical, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the clinical trial is to learn whether electrical nerve block is a safe and
      effective treatment for patients with post-amputation pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain reduction after each treatment session as measured by Numerical Rating Scale</measure>
    <time_frame>3 months post implant</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of all serious adverse events</measure>
    <time_frame>3 months post implant</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Medication Use</measure>
    <time_frame>12 months post implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain interference to Activities of Daily Living (ADL)</measure>
    <time_frame>12 months post implant</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life (HR-QOL)</measure>
    <time_frame>12 months post implant</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Post-Amputation Pain</condition>
  <condition>Phantom Limb Pain</condition>
  <condition>Residual Limb Pain</condition>
  <condition>Stump Pain</condition>
  <arm_group>
    <arm_group_label>Signal more likely to block nerve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electrical signal delivered to nerve by Altius, a device designed for high-frequency nerve block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Signal less likely to block nerve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Electrical signal delivered to nerve by Altius, a device designed for high-frequency nerve block</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Altius</intervention_name>
    <description>Electrical signal</description>
    <arm_group_label>Signal more likely to block nerve</arm_group_label>
    <arm_group_label>Signal less likely to block nerve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  One amputated lower limb

          -  Frequent and recurring amputation pain

          -  Residual limb pain and/or phantom limb pain

        Key Exclusion Criteria:

          -  Currently implanted with active medical device (e.g. pacemaker or drug pump)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonardo Kapural, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Clinical Research, Winston-Salem NC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neuros Medical, Inc.</name>
      <address>
        <city>Willoughby Hills</city>
        <state>Ohio</state>
        <zip>44094</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials</last_name>
      <email>ClinicalTrials@neurosmedical.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 30, 2016</lastchanged_date>
  <firstreceived_date>August 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Chronic</keyword>
  <keyword>Amputation</keyword>
  <keyword>Phantom Pain</keyword>
  <keyword>Stump Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Phantom Limb</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
